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Organisms react to environmental challenges by activating a coordinated set of brain–body
responses known as the stress response.These physiological and behavioral countermea-
sures are, in large part, regulated by the neuroendocrine hypothalamic–pituitary–adrenal
(HPA) axis. Normal functioning of the HPA axis ensures that an organism responds appro-
priately to altered environmental demands, representing an essential system to promote
survival. Over the past several decades, increasing evidence supports the hypothesis that
disruption of the HPA axis can lead to dysregulated stress response phenotypes, exacting
a physiological cost on the organism commonly referred to as allostatic load. Furthermore,
it has been recognized that high allostatic load can contribute to increased vulnerability
of the organism to further challenges. This observation leads to the notion that disrupted
HPA function and resulting inappropriate responses to stressors may underlie many neu-
ropsychiatric disorders, including depression and anxiety. In the present set of studies,
we investigate the role of both the normally functioning and disrupted HPA axis in the
endocrine, neural, and behavioral responses to acute stress. Using a model of non-invasive
chronic corticosterone treatment in mice, we show that dysregulating the normal function
of the HPA leads to a mismatch between the hormonal and neural response to acute
stress, resulting in abnormal behavioral coping strategies. We believe this model can be
leveraged to tease apart the mechanisms by which altered HPA function contributes to
neurobehavioral dysregulation in response to acute stress.
Keywords: corticosterone, allostatic load, prefrontal cortex, hippocampus, c-Fos
INTRODUCTION
The term stress carries with it negative connotations, but
it describes an important neurobehavioral and physiological
response that is essential for survival. In response to an envi-
ronmental stressor, the body quickly orchestrates changes in
brain activity followed shortly thereafter by secretion of “stress
mediators,” including cytokines, metabolic hormones, and cor-
ticosteroids (1–4). These circulating chemical messages then act
at peripheral tissues and in the brain to modify physiological
processes and behavioral outputs (1, 4). The primary neuroen-
docrine axis that regulates the stress response in mammals is
the hypothalamic–pituitary–adrenal (HPA) axis. Activation of this
system is initiated by projections from the brainstem and limbic
system to the paraventricular nucleus (PVN) of the hypothal-
amus (2–4). Upon activation, corticotropin-releasing hormone
(CRH) cells in the PVN secrete CRH onto proopiomelanocortin
(POMC)-containing cells at the median eminence, triggering
release of adrenocorticotropic hormone (ACTH) into the circula-
tion via activation of CRH receptors (2–6). As circulating ACTH
levels increase, melanocortin-2 receptors in the adrenal glands
are activated, leading to secretion of glucocorticoid hormones
(7), primarily cortisol in humans and corticosterone (CORT) in
rodents. Circulating CORT causes increased metabolic activity in
peripheral tissues and acts centrally at the brain via glucocorticoid
receptors (GRs) in order to induce negative feedback in the circuit
(1, 8). This negative feedback largely occurs via indirect connec-
tions to the hypothalamus [through the bed nucleus of the stria
terminalis (BNST) as well as through changes in endocannabi-
noid signaling in limbic, cortical, and subcortical brain regions]
(1, 4, 9, 10). It is well known that two main CORT responsive
brain regions – the medial prefrontal cortex (mPFC) and hip-
pocampal formation – act both directly and indirectly to inhibit
the drive to CORT production at the level of the amygdala and the
PVN (1–4), thus closing the loop and terminating the acute stress
response.
The stress response orchestrated by the HPA axis is well-
choreographed multi-system response, involving behavioral,
physiological, and metabolic responses, with tightly regulated
components that need to become active at the appropriate times
and in the appropriate contexts (11, 12). Thus, it is not surpris-
ing that disruptions in the biological response to stress can lead
to changes in neuronal function, behavior, and immune func-
tion (13–18). Disorders related to disrupted HPA function include
depression, post-traumatic stress disorder (PTSD), metabolic dys-
function, and anxiety disorders (8, 19–22). These disorders affect
millions worldwide, inflicting significant economic and personal
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costs. Developing animal models to understand how dysfunc-
tions in stress responses lead to altered behavioral outputs is
an important goal for modern neuroscience, and could lead to
direct translational benefits once mechanisms have been eluci-
dated. Thus, determining common themes in stress-related dis-
orders will be a useful approach in isolating relevant factors for
further mechanistic investigation.
Since many neuropsychiatric disorders are associated with
changes in basal HPA function, as well as with altered responses to
stressors, identifying the hormonal and neurobehavioral systems
that are affected could provide important insights as to potential
mechanisms by which these changes occur. Using low-dose CORT
administered in the drinking water of adult mice, our goal was
to determine how this treatment affects endocrine, neural, and
behavioral responses to acute stress. Our results show that this
non-invasive disruption of the HPA can fundamentally alter both
neural and behavioral responses to acute stress and demonstrate
that this can be a viable model for dissecting the mechanisms by
which HPA dysregulation results in inappropriate neurobehavioral
responses.
MATERIALS AND METHODS
ANIMALS AND CORTICOSTERONE TREATMENT
Adult male C57/BL6 mice (aged 35–42 days) were obtained from
Harlan Laboratories, Inc. Animals were allowed 1 week acclima-
tization time upon arrival prior to treatment. Animals were then
treated with vehicle (1% ethanol) or CORT (Sigma Aldrich, St.
Louis, MO, USA; 25µg/ml in 1% EtOH) for 28 days prior to test-
ing or tissue collection (23–25). Animal weights were measured
weekly and solutions were replaced during that time. All animal
experiments were conducted with approval of the Washington
State Institutional Animal Care and Use Committee.
FORCED-SWIM TEST
Acute stress was accomplished using the forced-swim test (FST).
Animals were subjected to 10-min FST (4 l glass beaker, water tem-
perature of 21–23°C) at ZT6. Following FST, animals were allowed
to recover for 10 min in their home cage prior to the open-field
test (OFT), blood collection, or RT-PCR. Time spent struggling
(defined as limb movements in excess of those needed to simply
stay afloat) or time spent immobile was scored by an experimenter
blinded to the conditions. Swim chambers were emptied, cleaned,
and refilled between each trial.
CORTICOSTERONE AND ADRENOCORTICOTROPIC HORMONE RIA
To determine changes in diurnal plasma CORT following vehi-
cle or chronic CORT treatment, a group of mice (N = 4–
5/group/time point) was killed by rapid decapitation at 6 h inter-
vals at zeitgeber times 0, 6, 12, and 18 (with ZT0 being time
of lights ON, and ZT12 being time of lights OFF). To deter-
mine endocrine stress responses, a separate group of mice was
killed 10 min after the 10-min FST by rapid decapitation (N = 4–
5/group/treatment). In both cases, trunk blood was collected in
EDTA-coated tubes. Brains from the FST group were then used
to detect stress-induced mRNA changes via RT-PCR (see below).
Blood was spun at 1500 rcf for 15 min in a refrigerated centrifuge,
and plasma removed, aliquoted, and stored at −80°C until assay.
Plasma was assayed for total CORT using the Siemens Coat-a-
Count kit for rat CORT according to the manufacturer’s protocol.
To further probe the endocrine response, plasma ACTH was mea-
sured in a previously unthawed plasma aliquot from a subset of
stressed vehicle- or CORT-treated mice (N = 5/group), with an
ACTH 125I Kit (DiaSorin, Inc., Stillwater, MN, USA) using the
option A (overnight incubation) protocol. For both assays, tubes
were counted on a Packard Cobra II gamma counter, and the
intrassay coefficient of variability was less than 10%.
NOVEL OPEN-FIELD TEST
To test behavioral responses following FST, an OFT was
conducted. The OFT consisted of a white plastic chamber
(27.5 cm× 27.5 cm× 20 cm). Lighting was set at 13–18 lux at
floor level. Ten minutes following the end of FST (or at ZT6
for unstressed controls,N = 8/group/treatment), each animal was
placed in the corner of the chamber and allowed to roam freely
for 5 min before being removed. The chamber was cleaned with
70% ethanol after each trial. Locomotor behavior was scored dig-
itally using Noldus Ethovision XT software (Leesburg, VA, USA).
Animal location was determined by the center point of the animal.
IN SITU HYBRIDIZATION FILM AUTORADIOGRAPHY
To detect CRH mRNA, in situ hybridization and film autora-
diography was used as previously described (26), with a mouse
CRH riboprobe generously provided by Dr. A. Jasnow, Kent State
University, OH, USA (27). Briefly, a separate group of unstressed
vehicle- or CORT-treated mice (25µg/ml; N = 4–5/group) was
killed via rapid decapitation at ZT6, and brains were removed
and immediately frozen on dry ice. Brain sections were made on
a cryostat (20µm thick) and mounted on slides. Slide-mounted
sections were fixed in 3.7% formaldehyde for 10 min, rinsed in
a series of phosphate-buffered saline (PBS) washes, followed by
rinses in triethanolamine-HCl (TEA) and TEA with acetic anhy-
dride. Slides were then washed in 2× sodium chloride citrate
(SCC) and dehydrated in a series of graded alcohols (70, 95, and
100%), delipidated in chloroform, and rinsed in 100% alcohol.
For pre-hybridization, slides were exposed to hybridization solu-
tion (225µl/slide), coverslipped, placed in a humidity chamber,
and incubated at 55°C for 1 h. Slides were then washed in 2×
SCC and again dehydrated in a series of graded alcohols (70
and 95%). For hybridization, slides were exposed to hybridiza-
tion buffer (225µl/slide) with the 35S-labeled antisense or sense
ribonucleotide probes (approximately 1× 106 cpm/slide), cover-
slipped, placed in a humidity chamber, and incubated at 55°C
overnight. Following hybridization, slides were washed in 2× SCC
buffer and incubated with RNase A (10µg/ml) in digestion buffer
at 37°C for 30 min and then digestion buffer alone for 10 min.
Slides were then rinsed in series of 2× SCC and 0.2× SCC washes
at 55°C and dehydrated in a series of graded alcohols. Slides were
air dried for 24 h and then apposed to Kodak BioMax MR film
(Sigma) for 2 days to generate autoradiograms.
QUANTIFICATION OF CRH mRNA
Relative optical densities (RODs) were measured from the autora-
diograms using computerized image analysis software (MCID-
M4, Imaging Research, Inc., St. Catharines, Canada). Background
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measurements were made from areas adjacent to the PVN and
subtracted from the ROD. The same size circular tool, smaller
than the size of the brain region (PVN or amygdala) being mea-
sured, was used to ensure that the same size sample was measured
from section to section, and mouse to mouse. At least two bilateral
measurements were made for each mouse.
QUANTITATIVE RT-PCR
As above, brains from each group were collected 10 min after
the end of a 10-min FST (N = 4–5/group/treatment), and frozen
immediately on dry ice. Brain regions of interest were punched
using 0.5 mm ID biopsy corer (Fine Science Tools, Foster City, CA,
USA) and kept at−80°C until extraction. mRNA isolation was per-
formed using Qiazol (Trizol-chloroform) extraction with RNeasy
column clean-up (Qiagen, Valencia, CA, USA). Samples were
stored at −80°C in 1 mM sodium citrate, pH 6.4 (Life Technolo-
gies, Grand Island, NY, USA) prior to cDNA synthesis. mRNA con-
centrations were measured using spectrophotometry and diluted
to the same concentration for all samples. cDNA synthesis was pre-
formed with MultiScribe™ MuLV reverse-transcriptase following
the protocol for the high capacity cDNA synthesis kit (Life Tech-
nologies). cDNA was stored at −20°C. cDNA synthesis reaction
was preformed in triplicate for vHC samples. Assays were per-
formed using the TaqMan chemistry and off the shelf assays from
Life Technologies. Assay IDs were: Gapdh-Mm99999915_g1 and
cFos-Mm00487425_m1. Samples were run in triplicate on a Life
Technologies 7900HT real-time PCR machine with a 20µl reac-
tion volume. Samples were compared using the ∆∆CT method
of relative quantification. GAPDH was used to normalize between
biological replicates.
STATISTICS
All statistical analyses were accomplished using Prism 5 (GraphPad
Software, La Jolla, CA, USA). Two-tailed t -tests and one-way or
two-way ANOVAs were undertaken where appropriate, and Tukey
post hoc tests were used to probe interactions. In all cases, results
were considered statistically significant at the P = 0.05 level.
RESULTS
CORT TREATMENT DOES NOT AFFECT BODY WEIGHT
After 4 weeks of treatment, no statistically significant difference
was observed in weight gained between chronic CORT-treated ani-
mals and vehicle-treated animals (data not shown; F1,37= 0.7057,
P = 0.4063), replicating results from our previous work in this
model (23, 25).
CORT TREATMENT RESULTS IN ALTERED DIURNAL PATTERNS OF
PLASMA CORT
After 4 weeks of treatment, mice (N = 4–5/group) were killed at
one of four time points: lights ON (ZT0), mid-light (ZT6), lights
OFF (ZT12), and mid-night (ZT18). A significant main effect
was detected for both treatment (two-way ANOVA; F1,25= 44.29,
P < 0.0001) and time (F3,25= 13.39, P < 0.0001), as well as a sig-
nificant interaction (F3,25= 16.75, P < 0.0001). Tukey post hoc
analysis showed that chronic CORT resulted in higher plasma
CORT levels at both ZT18 and ZT0 (both P < 0.001), but nadir
levels were statistically indistinguishable from vehicle-treated mice
at ZT6 and ZT12 (both P > 0.05; Figure 1).
FIGURE 1 | Chronic low-dose CORT treatment in the drinking water
maintains rhythmic, yet slightly higher, levels of plasma CORT.
Treatment with CORT (25µg/ml) in the drinking water resulted in rhythmic
diurnal changes in plasma CORT that reached a peak during the dark phase
(ZT12–ZT0), but reached the same nadir levels as vehicle-treated mice
(ZT6). Data from 0′ to 18′ are re-plotted from 0 to 18 to aid in visualization of
the rhythm. Asterisks indicate statistically significant effects at the P <0.05
level.
CORT TREATMENT RESULTS IN A BLUNTING OF THE ENDOGENOUS
STRESS RESPONSE
To determine how chronic CORT affects the peripheral
(endocrine) stress response, we exposed CORT-treated mice to
an acute FST stress. Given that ZT6 basal CORT levels were not
different between vehicle- and chronic CORT-treated mice, we
tested the endogenous hormonal stress response 10 min after a
10-min FST (N = 4–5/group). We found main effects of both
CORT treatment (two-way ANOVA, F1,15= 161.6, P < 0.0001)
and stress (F1,15= 187.7, P < 0.0001), and a significant interac-
tion (F1,15= 106.0, P < 0.0001). Tukey post hoc analysis showed
that FST resulted in increased CORT only in vehicle-treated mice
(P < 0.05), while stressed chronic CORT mice showed no increase
in plasma CORT over basal levels (P > 0.05). There were no dif-
ferences in non-stressed levels of plasma CORT between vehicle-
and chronic CORT-treated mice (Figure 2). In a subset of only
FST mice (N = 4–5/group), we also measured plasma ACTH at
the same time point as CORT (Figure S1 in Supplementary Mater-
ial), showing that CORT treatment blocked the normal increase in
plasma ACTH following FST (t -test, t = 5.257, P = 0.0012). This
suggests the endogenous hormonal stress response is impaired in
CORT-treated mice.
CHRONIC CORT TREATMENT REDUCES CORTICOTROPIN-RELEASING
HORMONE mRNA IN THE PARAVENTRICULAR NUCLEUS, BUT NOT THE
AMYGDALA
To determine the effects of chronic CORT on central HPA func-
tion, using in situ hybridization, we assayed CRH mRNA levels
following vehicle or CORT treatment (N = 4/group) within the
PVN of the hypothalamus, a key central node in the HPA axis,
and the amygdala (Figure 3). We found a main effect of CORT
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FIGURE 2 | Chronic low-dose CORT treatment blocks the normal
endocrine response to stress. Treatment with CORT (25µg/ml) in the
drinking water for 4 weeks resulted in reduced CORT secretion following a
10-min forced-swim stress at ZT6, with no effect on basal plasma CORT
levels. Asterisk indicates statistically significant difference at the P <0.05
level.
FIGURE 3 | Chronic low-dose CORT treatment reduced CRH mRNA
expression in the PVN but does not affect expression in the amygdala.
In situ hybridization showed that treatment with CORT (25µg/ml) in the
drinking water for 4 weeks resulted in a statistically significant decrease in
CRH mRNA expression in the PVN, but not in the amygdala. Asterisk
indicates statistically significant difference at the P <0.05 level.
treatment and brain region (two-way ANOVA, F1,12= 15.15.,
P = 0.002; F1,12= 5.602,P = 0.0356), and a significant interaction
(F1,12= 27.21, P = 0.0002). Tukey post hoc analysis demonstrates
that CRH mRNA levels are reduced in the PVN following 4 weeks
of CORT treatment (P < 0.05), while CRH mRNA in the amygdala
remained unaffected, compared to controls.
STRESS RESULTS IN EXAGGERATED c-Fos mRNA EXPRESSION IN
CORT-TREATED MICE
To determine if the blunting of the hormonal stress response was
accompanied by changes in neural activation following the stress,
we investigated changes in c-Fos mRNA using quantitative RT-
PCR in the dorsal and ventral hippocampus (dHipp and vHipp), as
FIGURE 4 |Treatment with CORT in the drinking water results in
exaggerated stress-induced c-Fos responses in the brain. Following a
10-min forced-swim stress and a 10-min recovery period, CORT (25µg/ml)
drinking water-treated mice showed an exaggerated c-Fos mRNA response
as measured by RT-PCR in (A) the dorsal hippocampus, (B) the ventral
hippocampus, and (C) the prefrontal cortex. CORT treatment did not affect
basal non-stressed levels of c-Fos. Columns that share the same letter are
not statistically different from each other at the P <0.05 level.
well as in the prefrontal cortex (PFC) 10 min after the termination
of a 10-min FST (Figure 4, N = 4–5/group).
In the dHipp (Figure 4A), we found significant main effects
of both stress (two-way ANOVA, F1,15= 149.4, P < 0.0001) and
CORT treatment (F1,15= 10.81,P = 0.005), as well as a significant
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interaction (F1,15= 9.366, P = 0.0079). Tukey post hoc analy-
sis showed that while stress increased dHipp c-Fos mRNA,
the increase was greater in the chronic CORT-treated mice
(P < 0.05), while there was no difference in non-stressed basal
c-Fos expression.
Similarly, in the vHipp (Figure 4B), we found significant main
effects of stress (F1,14= 64.81, P < 0.0001) and chronic CORT
treatment (F1,14= 7.150,P = 0.0182), as well as a significant inter-
action (F1,14= 7.655,P = 0.0151). Post hoc analysis indicated that,
as in the dHipp, stress increased c-Fos, but this increase was greater
in the chronic CORT mice (P < 0.05), without any differences in
the non-stressed basal expression of c-Fos.
In the PFC (Figure 4C), while we found a significant
main effect of stress (F1,15= 373.2, P < 0.0001), we did not
find a statistically significant main effect of CORT treatment
(F1,15= 2.282,P = 0.1516). However, there was a significant inter-
action (F1,15= 10.75,P = 0.0051), with Tukey post hoc tests reveal-
ing a similar pattern where CORT-treated mice show enhanced
c-Fos expression in the PFC following stress compared to vehicle-
treated mice (P < 0.05), with no effect on non-stressed basal c-Fos
expression.
Thus, in all instances, while chronic CORT does not affect basal
non-stressed c-Fos expression, it does result in a statistically sig-
nificant increase in c-Fos expression following FST in the dHipp,
vHipp, and PFC.
CHRONIC CORT TREATMENT RESULTS IN ALTERED BEHAVIORAL
RESPONSES FOLLOWING STRESS
Given the altered hormonal and gene expression responses fol-
lowing acute FST stress in CORT-treated mice, we next wanted
to determine if prior CORT treatment causes changes in acute
stress-induced behavior. To these ends, we investigated stress-
induced changes in swim behaviors in the FST, as well as
rearing and grooming behavior in a novel open-field environ-
ment in vehicle- or CORT-treated mice, with or without stress
(N = 8/group/treatment; Figure 5).
Behavior in the FST
Struggling in the FST was scored to determine if there was any
effect of chronic low-dose CORT treatment on activity in the FST
that may contribute to altered responses in rearing or groom-
ing. We found that 4 weeks of chronic CORT did not affect
time struggling or time spent immobile in the FST (Figure 5A;
two-tailed t -test, t = 1.594, P = 0.13). We also found no effect
of low-dose CORT on latency to immobility (data not shown;
vehicle 58.63± 4.769 s vs. CORT 51.25± 2.782 s; two-tailed t -test,
t = 1.336, P = 0.203).
Rearing behavior
One episode of forced-swim stress resulted in statistically sig-
nificant differences in the frequency of rearing behavior in the
OFT (Figure 5B). While there was a main effect of FST stress
(F1,28= 16.64, P = 0.0003) and CORT treatment (F1,28= 11.64,
P = 0.0020) on rearing frequency, there was also a statisti-
cally significant interaction between stress and CORT treatment
(F1,28= 10.68, P = 0.0029). Post hoc analyses revealed that VEH
mice showed a significant decrease in grooming (P < 0.0003).
FIGURE 5 | Chronic low-dose CORT does not affect behavior in the FST,
but blocks normal stress-induced anxiety behaviors in a novel
environment after the FST. Four weeks of CORT (25µg/ml) in the drinking
water does not alter time spent immobile in the FST (A). Following the FST,
vehicle-treated mice show subsequent anxiety-like behavior in an open field
as measured by decreased rearing (B) and increased grooming (C), while
CORT-treated mice are statistically indistinguishable from controls,
suggesting they do not show normal stress-induced anxiety-like behavior.
Asterisks indicate statistically significant differences at the P <0.05 level.
However, no statistically significant difference in rearing frequency
was observed between stress/CORT animals and non-stress/VEH
animals (P = 0.9645) or non-stress/CORT animals (P = 0.9392),
suggesting chronic CORT blocked the normal stress-induced
decreases in rearing behavior.
Grooming behavior
Similar to the effects on rearing behavior, FST and CORT treat-
ment resulted in main effects on grooming duration (Figure 5C;
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F1,27= 62.36, P < 0.0001 and F1,27= 20.83, P < 0.0001, respec-
tively). However, there was also a statistically significant inter-
action between stress and CORT treatment (F1,27= 19.60,
P < 0.0001). Post hoc analyses revealed that FST increased groom-
ing duration in VEH-treated mice (P < 0.0001). However, no
statistically significant difference in grooming duration was
observed between stress/CORT mice and non-stress/VEH mice
(P = 0.1191), or non-stress/CORT mice (P = 0.0832), further sup-
porting the notion that CORT induced disruption of the HPA
blocks normal behavioral responses to acute stress.
DISCUSSION
The stress response is an essential brain–body response that pro-
tects homeostasis and ensures survival in the face of threatening
environmental stimuli (12, 28–30). The coordinated response fol-
lowing stress allows for mediators of allostasis to mobilize and
allow an organism to adapt to a temporary environmental shift.
As such, these responses can be considered protective, and in fact,
healthy allostatic responses are a sign of resilience (31–33). How-
ever, if allostatic mediators are over active, improperly regulated,
poorly terminated, or engaged inappropriately, allostatic load can
increase. Eventually this results in allostatic overload, which, rather
than protecting the organism, leads to a series of cascading failures
in multiple physiological systems. Thus, the systems that usually
impart resilience instead result in increased vulnerability (12, 31,
32, 34). Given the central role of the HPA axis stress response
in allostatic responses, we probed how our model of disrupted
HPA function might lead to altered neural and behavioral outputs,
and perhaps contribute to negative mental and physical health
outcomes.
Disruption of normal HPA function is a hallmark of a varied set
of physical and neuropsychiatric diseases, such as obesity, depres-
sion, and anxiety (21, 22, 35). For example, PTSD is associated with
dysregulated HPA function. Even though some reports suggest a
hyperactive HPA is related to development of PTSD (36, 37), while
others propose that HPA hypoactivity may be a key factor (38–40),
the overarching theme remains: that in PTSD the HPA is disrupted
and does not respond normally to stressors. Whether these changes
in HPA activity are a cause or consequence of such disease states is
unclear, though it is feasible that disrupting the normal responses
to environmental stress could predispose individuals to negative
health outcomes. In the present study, we explored how disrup-
tion of the HPA via a non-invasive drinking water treatment could
change the normal neuroendocrine stress response, and how this
change would affect both neural and behavioral outputs following
exposure to an acute stress.
The present study used a non-invasive manipulation of the HPA
that maintains near normal diurnal changes in plasma CORT, but
interferes with the neuroendocrine stress response. This model is
a variant of more classic approaches used in adrenalectomized rats
(41, 42). In our model, mice treated with a low-dose (25µg/ml)
of CORT in the drinking water for 4 weeks show normal growth
curves (23) and show a diurnal rhythm in plasma CORT that
is somewhat higher, and peaks slightly later, than CORT in un-
manipulated mice (Figure 1). In the present study, we further
report that this model results in the shutdown of the normal
endocrine response to forced-swim stress, with no increase in
plasma CORT observed following the stress (Figure 2). This is
likely due to both peripheral, as we have previously demonstrated
that it also leads to atrophy of the adrenal gland (23, 25), as well as
central effects, since we observed a decrease in PVN CRH mRNA
(Figure 3). Given this altered plasma CORT response, the purpose
of the second part of the study was to determine if disruption of the
HPA response would result in differential neural and behavioral
responses to acute stress.
Acute stress results in a sequence of neural and behavioral
responses, and perturbations of these normal responses may indi-
cate underlying faults in the neural and endocrine systems regu-
lating stress reactivity. Following stress, brain c-Fos expression is
increased in the PFC and HIPP, as well as in a number of other
brain areas (43–45), suggesting increased neuronal activity. How-
ever, the consequences of altered HPA function for stress-induced
c-Fos expression are unclear. Some reports indicate that ADX has
no effect on acute stress-induced c-Fos mRNA (46), while oth-
ers describe increases in stress-induced c-Fos expression following
ADX (47, 48). Given these somewhat conflicting reports, we chose
to explore both neural and behavioral responses in a model of
HPA dysfunction. In our model, the normally observed increase
in plasma CORT following stress is abolished (Figure 2), and levels
of PVN CRH mRNA are reduced (Figure 3). This led us to posit
that normal neural responses to stress would also be blunted, given
that the primary neuroendocrine output of the stress response is
greatly reduced. However, our hypothesis was proven incorrect,
and instead we observed increased neural responses in the brain
regions we explored (Figure 4).
Following stress, many brain regions in addition to the PFC
and HIPP show increased activity (2, 3, 46, 49), forming an almost
brain-wide network from the brain stem through to the forebrain.
For instance, in response to a novel environmental stressor, nora-
drenergic neurons of the locus ceruleus (LC) rapidly increase firing
rate. These cells are known to project to forebrain regions such
as the PFC and HIPP where they play a largely excitatory role
(50, 51). Many of these same areas are also intimately involved
in the negative feedback aspect of the stress response, with acti-
vation of the GR serving to reduce their activity. For example, in
ADX rats, a single bolus injection of CORT leads to a decrease
in c-Fos expression in the dorsal HIPP within 45 min (52). In
the present study, we determined that even though our model
results in decreased plasma CORT in response to stress (Figure 2),
neural activation (as measured by c-Fos mRNA) is significantly
increased in the PFC, as well as the dorsal and ventral hippocam-
pus (dHipp and vHipp; Figure 4). These novel and unexpected
findings have led us to hypothesize that the lack of a normal
endogenous CORT response in exogenous CORT-treated animals
may deprive these circuits of a key negative feedback signal. Such
attenuation of neural activity by glucocorticoids has been observed
in LC noradrenergic neurons, where activation of the GR in LC
neurons decreases tyrosine hydroxylase mRNA and presumably
reduces neuronal activity (53). This leads to a possible mecha-
nism that explains the observed increased c-Fos expression in the
mPFC and hippocampus in CORT-treated animals: i.e., it is possi-
ble that without the inhibitory drive of CORT to the LC following a
stressor, mPFC and hippocampal activity is increased above “nor-
mal” levels via overstimulation by noradrenergic LC afferents to
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these regions. Such an outcome could be tested in future studies
by specifically manipulating different components of this circuit,
with or without chronic CORT treatment.
Given the obvious differences in both hormonal and neural
responses to stress in CORT-treated mice, and to clarify the func-
tional consequences of these altered responses, we next wanted to
explore changes in behavioral outputs following stress. It is well
documented that acute stress can lead to increased anxiety-like
behaviors in rodents on a variety of measures, including the ele-
vated plus maze, open field, and social avoidance (54–58). These
alterations in behavior are mediated by both neural and hor-
monal changes during and following the stressor. To determine the
behavioral consequences of a blunted hormonal stress response,
but exaggerated neural stress response, we analyzed behavioral
changes in the novel environment of an open field following a
forced-swim stress (Figure 5). Rearing in a novel open field can be
considered a form of exploratory behavior (59), associated with
positive affective states and thus indicative of low anxiety (60). Our
results indicate that in response to an acute stressor, animals chron-
ically treated with CORT fail to display the normally observed
decrease in rearing behavior. From this, we conclude that CORT
treatment reduces anxiety responses normally elicited by a novel
acute stress. Similarly, self-grooming behavior in rodents has been
associated with high levels of anxiety (61, 62). In the present study,
we observe lower duration of grooming in CORT-treated animals
compared to those treated with vehicle in response to an acute
stress. Chronic CORT-treated animals resemble non-stressed ani-
mals in that grooming duration does not significantly increase
following stress. Thus, we conclude that the failure to increase
grooming duration following acute stress in CORT-treated com-
pared to vehicle-treated mice again suggests a lower anxiety state
in CORT-treated mice. It is important to note that we did not
find behavioral differences between the vehicle and CORT groups
in the FST (Figure 5A), suggesting the neural and behavioral
responses after FST are not simply due to differences in amount
of exercise or stress coping strategies. Gourley et al. noted a slight
increase in immobility in the tail suspension test using a simi-
lar model (63), but it is important to note that their results used
CORT hemisuccinate (that may alter bioavailability), and a 3-day
“washout” period, making direct comparison difficult as our mice
were still being treated with CORT at time of testing. We conclude
that disrupting the HPA axis using this model of chronic CORT
in the drinking water blocks normal behavioral responses to acute
stress.
The behavior of CORT-treated mice following acute stress is
statistically indistinguishable from non-stressed mice with respect
to grooming and rearing behaviors in the open field (Figure 5).
On the other hand, activity in the PFC and HIPP clearly shows
significant increase in c-Fos expression, to a level greater than
both stressed vehicle mice as well as non-stressed vehicle or CORT
mice (Figure 4). Thus, there appears to be a mismatch between
the neural and behavioral responses to stress in CORT-treated
mice that have a dysregulated HPA. It is intriguing to consider
the ramifications of such “inappropriate” behavioral and neural
responses following stress. One interpretation could be that the
inability of CORT-treated mice to increase plasma CORT lev-
els following a stressor results in a protective phenotype that
does not show increases in anxiety-like behavior. However, such
resilience should not necessarily be construed as a beneficial con-
sequence to the organism, as blunted reactions to stress could
be maladaptive. Acute environmental stressors produce neces-
sary neurobehavioral responses that improve chances for survival
in challenging environments. For instance, in many cases, mem-
ory and learning processes are increased by acute stress (64–66),
with the presumed benefit of allowing for future avoidance of the
stressor or context in which the stressor occurred (67). Restated,
behavioral, and physiological phenotypes normally expressed fol-
lowing exposure to acute stress are thought to be adaptive. Thus,
reduction of these behaviors by HPA dysregulation observed here
could be described as maladaptive. This suggests it is equally plau-
sible to consider the alternative interpretation: that the lack of
a behavioral response following a stressor, in association with
increased activity in the PFC and HIPP, may have negative con-
sequences because the appropriate allostatic mediators are not
being adequately mobilized, and/or their termination is not being
efficiently regulated. Perhaps in the short term, such responses
have little negative impact, but repeated stress exposure without
the normal hormonal, neural, or behavioral responses may con-
tribute to increased allostatic load and eventual long-term negative
outcomes.
The results of our study suggest the low-dose CORT model
(without ADX) may be useful in the investigation of disorders in
which a dysregulation of the HPA axis, or other aspects of the stress
response, are observed, such as PTSD, depression, and anxiety dis-
orders. As we have shown that many gross markers of adrenal status
recover after removal of the CORT treatment (25), the reversibility
of this model could provide insight into long-term effects of short-
term HPA dysregulation. By devising models that can be dissected
both anatomically and temporally, we may gain increased under-
standing of the neural and behavioral underpinnings of complex
neuropsychiatric disorders.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at http://www.frontiersin.org/Journal/10.3389/fpsyt.2015.00031/
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